Cargando…

Surviving 2019 novel coronavirus pneumonia: A successful critical case report

BACKGROUND: . An outbreak of acute respiratory illness was proved to be infected by a novel coronavirus, officially named Coronavirus Disease 2019 (COVID-19) from World Health Organization (WHO), was confirmed first in Wuhan, China, and has become endemic worldwide, which was a serious threaten to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Lei, Sun, Jiakui, Liu, Ying, Zhang, Wenhao, Jiang, Wei, Yuan, Shoutao, Shi, Qiankun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440228/
https://www.ncbi.nlm.nih.gov/pubmed/32861887
http://dx.doi.org/10.1016/j.hrtlng.2020.08.009
_version_ 1783573128057716736
author Zou, Lei
Sun, Jiakui
Liu, Ying
Zhang, Wenhao
Jiang, Wei
Yuan, Shoutao
Shi, Qiankun
author_facet Zou, Lei
Sun, Jiakui
Liu, Ying
Zhang, Wenhao
Jiang, Wei
Yuan, Shoutao
Shi, Qiankun
author_sort Zou, Lei
collection PubMed
description BACKGROUND: . An outbreak of acute respiratory illness was proved to be infected by a novel coronavirus, officially named Coronavirus Disease 2019 (COVID-19) from World Health Organization (WHO), was confirmed first in Wuhan, China, and has become endemic worldwide, which was a serious threaten to public health all over the world. Herein, we reported a successful critical case of COVID-19 and shared our experience of treatment, which would do a favor for other COVID-19 patients. CASE SUMMARY: . A 65-year-old man, Wuhan citizen, was infected by COVID-19, and his pulmonary lesions progressed quickly in five days. On admission to Tongji Hospital, Wuhan, China, the immediate arterial blood gas(ABG) analysis showed the PaO2/FiO2(P/F) ratio was 134.4mmHg, moderate acute respiratory distress syndrome(ARDS) was diagnosed. Emergency tracheal intubation was performed, and the initial ventilator mode and parameters were set up based on the lung-protective ventilation strategy, but the P/F ratio could not be improved, and then the prone position ventilation was carried out for four consecutive days, as long as 16 hours every day, the P/F ratio rose to 180mmHg approximately, which still did not reach to the standard of extubation. And then we found that it was complicated with acute cor pulmonale(ACP) by ultrasound examination, dobutamine and diuretic were used for the treatment of ACP caused by ARDS successfully, and the P/F ratio went up to about 250mmHg. Seven days later after admission, the endotracheal intubation was successfully removed, after extubation, High-Flow nasal cannula(HFNC) oxygen therapy was used as a sequential strategy to prevent reintubation. Ultimately, he was discharged on day 34 after admission. CONCLUSION: . Our case presented the treatment process of a critical COVID-19. Effective therapy was crucial to heal COVID-19, and organ function support therapy, especially the cardiorespiratory function support therapy, was the core of treatment.
format Online
Article
Text
id pubmed-7440228
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-74402282020-08-21 Surviving 2019 novel coronavirus pneumonia: A successful critical case report Zou, Lei Sun, Jiakui Liu, Ying Zhang, Wenhao Jiang, Wei Yuan, Shoutao Shi, Qiankun Heart Lung Article BACKGROUND: . An outbreak of acute respiratory illness was proved to be infected by a novel coronavirus, officially named Coronavirus Disease 2019 (COVID-19) from World Health Organization (WHO), was confirmed first in Wuhan, China, and has become endemic worldwide, which was a serious threaten to public health all over the world. Herein, we reported a successful critical case of COVID-19 and shared our experience of treatment, which would do a favor for other COVID-19 patients. CASE SUMMARY: . A 65-year-old man, Wuhan citizen, was infected by COVID-19, and his pulmonary lesions progressed quickly in five days. On admission to Tongji Hospital, Wuhan, China, the immediate arterial blood gas(ABG) analysis showed the PaO2/FiO2(P/F) ratio was 134.4mmHg, moderate acute respiratory distress syndrome(ARDS) was diagnosed. Emergency tracheal intubation was performed, and the initial ventilator mode and parameters were set up based on the lung-protective ventilation strategy, but the P/F ratio could not be improved, and then the prone position ventilation was carried out for four consecutive days, as long as 16 hours every day, the P/F ratio rose to 180mmHg approximately, which still did not reach to the standard of extubation. And then we found that it was complicated with acute cor pulmonale(ACP) by ultrasound examination, dobutamine and diuretic were used for the treatment of ACP caused by ARDS successfully, and the P/F ratio went up to about 250mmHg. Seven days later after admission, the endotracheal intubation was successfully removed, after extubation, High-Flow nasal cannula(HFNC) oxygen therapy was used as a sequential strategy to prevent reintubation. Ultimately, he was discharged on day 34 after admission. CONCLUSION: . Our case presented the treatment process of a critical COVID-19. Effective therapy was crucial to heal COVID-19, and organ function support therapy, especially the cardiorespiratory function support therapy, was the core of treatment. Elsevier Inc. 2020 2020-08-20 /pmc/articles/PMC7440228/ /pubmed/32861887 http://dx.doi.org/10.1016/j.hrtlng.2020.08.009 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zou, Lei
Sun, Jiakui
Liu, Ying
Zhang, Wenhao
Jiang, Wei
Yuan, Shoutao
Shi, Qiankun
Surviving 2019 novel coronavirus pneumonia: A successful critical case report
title Surviving 2019 novel coronavirus pneumonia: A successful critical case report
title_full Surviving 2019 novel coronavirus pneumonia: A successful critical case report
title_fullStr Surviving 2019 novel coronavirus pneumonia: A successful critical case report
title_full_unstemmed Surviving 2019 novel coronavirus pneumonia: A successful critical case report
title_short Surviving 2019 novel coronavirus pneumonia: A successful critical case report
title_sort surviving 2019 novel coronavirus pneumonia: a successful critical case report
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440228/
https://www.ncbi.nlm.nih.gov/pubmed/32861887
http://dx.doi.org/10.1016/j.hrtlng.2020.08.009
work_keys_str_mv AT zoulei surviving2019novelcoronaviruspneumoniaasuccessfulcriticalcasereport
AT sunjiakui surviving2019novelcoronaviruspneumoniaasuccessfulcriticalcasereport
AT liuying surviving2019novelcoronaviruspneumoniaasuccessfulcriticalcasereport
AT zhangwenhao surviving2019novelcoronaviruspneumoniaasuccessfulcriticalcasereport
AT jiangwei surviving2019novelcoronaviruspneumoniaasuccessfulcriticalcasereport
AT yuanshoutao surviving2019novelcoronaviruspneumoniaasuccessfulcriticalcasereport
AT shiqiankun surviving2019novelcoronaviruspneumoniaasuccessfulcriticalcasereport